BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Barrios C, Beaumont M, Pallister T, Villar J, Goodrich JK, Clark A, Pascual J, Ley RE, Spector TD, Bell JT, Menni C. Gut-Microbiota-Metabolite Axis in Early Renal Function Decline.PLoS One. 2015;10:e0134311. [PMID: 26241311 DOI: 10.1371/journal.pone.0134311] [Cited by in Crossref: 72] [Cited by in F6Publishing: 66] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Graboski AL, Redinbo MR. Gut-Derived Protein-Bound Uremic Toxins. Toxins (Basel) 2020;12:E590. [PMID: 32932981 DOI: 10.3390/toxins12090590] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Jaskiw GE, Obrenovich ME, Kundrapu S, Donskey CJ. Changes in the Serum Metabolome of Patients Treated With Broad-Spectrum Antibiotics. Pathog Immun 2020;5:382-418. [PMID: 33474520 DOI: 10.20411/pai.v5i1.394] [Reference Citation Analysis]
3 Lindahl A, Heuchel R, Forshed J, Lehtiö J, Löhr M, Nordström A. Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics. Metabolomics 2017;13:61. [PMID: 28413374 DOI: 10.1007/s11306-017-1199-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
4 Carroccio A, Celano G, Cottone C, Sclafani GD, Vannini L, D'Alcamo A, Vacca M, Calabrese FM, Mansueto P, Soresi M, Francavilla R, De Angelis M. WHOLE-meal ancient wheat-based diet: Effect on metabolic parameters and microbiota. Dig Liver Dis 2021:S1590-8658(21)00209-7. [PMID: 34024731 DOI: 10.1016/j.dld.2021.04.026] [Reference Citation Analysis]
5 Raimondi S, Calvini R, Candeliere F, Leonardi A, Ulrici A, Rossi M, Amaretti A. Multivariate Analysis in Microbiome Description: Correlation of Human Gut Protein Degraders, Metabolites, and Predicted Metabolic Functions. Front Microbiol 2021;12:723479. [PMID: 34603248 DOI: 10.3389/fmicb.2021.723479] [Reference Citation Analysis]
6 Gryp T, Vanholder R, Vaneechoutte M, Glorieux G. p-Cresyl Sulfate. Toxins (Basel) 2017;9:E52. [PMID: 28146081 DOI: 10.3390/toxins9020052] [Cited by in Crossref: 136] [Cited by in F6Publishing: 117] [Article Influence: 27.2] [Reference Citation Analysis]
7 Chowdhury MR, Mas-ud MA, Ali MR, Fatamatuzzohora M, Shimu AS, Haq MA, Islam MA, Hossain MF, Hosenuzzaman M, Islam MM, Hasan MF, Matin MN. Harmful Effects of COVID-19 on Major Human Body Organs: A Review. J Pure Appl Microbiol 2021;15:500-11. [DOI: 10.22207/jpam.15.2.14] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Li Y, Cao H, Wang X, Guo L, Ding X, Zhao W, Zhang F. Diet-mediated metaorganismal relay biotransformation: health effects and pathways. Crit Rev Food Sci Nutr 2021;:1-19. [PMID: 34802351 DOI: 10.1080/10408398.2021.2004993] [Reference Citation Analysis]
9 Zhang J, Luo D, Lin Z, Zhou W, Rao J, Li Y, Wu J, Peng H, Lou T. Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome. Microb Pathog 2020;147:104359. [PMID: 32599137 DOI: 10.1016/j.micpath.2020.104359] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 Beebe K, Kennedy AD. Sharpening Precision Medicine by a Thorough Interrogation of Metabolic Individuality. Comput Struct Biotechnol J 2016;14:97-105. [PMID: 26929792 DOI: 10.1016/j.csbj.2016.01.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
11 Briskey D, Tucker P, Johnson DW, Coombes JS. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development. Clin Exp Nephrol 2017;21:7-15. [DOI: 10.1007/s10157-016-1255-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 5.2] [Reference Citation Analysis]
12 Alagiakrishnan K, Halverson T. Holistic perspective of the role of gut microbes in diabetes mellitus and its management. World J Diabetes 2021; 12(9): 1463-1478 [PMID: 34630900 DOI: 10.4239/wjd.v12.i9.1463] [Reference Citation Analysis]
13 Wu IW, Gao SS, Chou HC, Yang HY, Chang LC, Kuo YL, Dinh MCV, Chung WH, Yang CW, Lai HC, Hsieh WP, Su SC. Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease. Theranostics 2020;10:5398-411. [PMID: 32373220 DOI: 10.7150/thno.41725] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
14 Niska-Blakie J, Gopinathan L, Low KN, Kien YL, Goh CMF, Caldez MJ, Pfeiffenberger E, Jones OS, Ong CB, Kurochkin IV, Coppola V, Tessarollo L, Choi H, Kanagasundaram Y, Eisenhaber F, Maurer-Stroh S, Kaldis P. Knockout of the non-essential gene SUGCT creates diet-linked, age-related microbiome disbalance with a diabetes-like metabolic syndrome phenotype. Cell Mol Life Sci 2020;77:3423-39. [PMID: 31722069 DOI: 10.1007/s00018-019-03359-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
15 Feng YL, Cao G, Chen DQ, Vaziri ND, Chen L, Zhang J, Wang M, Guo Y, Zhao YY. Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease. Cell Mol Life Sci 2019;76:4961-78. [PMID: 31147751 DOI: 10.1007/s00018-019-03155-9] [Cited by in Crossref: 48] [Cited by in F6Publishing: 41] [Article Influence: 16.0] [Reference Citation Analysis]
16 Manor O, Zubair N, Conomos MP, Xu X, Rohwer JE, Krafft CE, Lovejoy JC, Magis AT. A Multi-omic Association Study of Trimethylamine N-Oxide. Cell Rep 2018;24:935-46. [PMID: 30044989 DOI: 10.1016/j.celrep.2018.06.096] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 29.0] [Reference Citation Analysis]
17 Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S, Consolandi C, Quercia S, Scurti M, Monti D. Gut Microbiota and Extreme Longevity. Curr Biol. 2016;26:1480-1485. [PMID: 27185560 DOI: 10.1016/j.cub.2016.04.016] [Cited by in Crossref: 313] [Cited by in F6Publishing: 282] [Article Influence: 52.2] [Reference Citation Analysis]
18 Sampaio-maia B, Simões-silva L, Pestana M, Araujo R, Soares-silva I. The Role of the Gut Microbiome on Chronic Kidney Disease. Elsevier; 2016. pp. 65-94. [DOI: 10.1016/bs.aambs.2016.06.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
19 Rosas-Villegas A, Sánchez-Tapia M, Avila-Nava A, Ramírez V, Tovar AR, Torres N. Differential Effect of Sucrose and Fructose in Combination with a High Fat Diet on Intestinal Microbiota and Kidney Oxidative Stress. Nutrients 2017;9:E393. [PMID: 28420148 DOI: 10.3390/nu9040393] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 6.4] [Reference Citation Analysis]
20 Ferrucci L, Fabbri E. Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol. 2018;15:505-522. [PMID: 30065258 DOI: 10.1038/s41569-018-0064-2] [Cited by in Crossref: 552] [Cited by in F6Publishing: 505] [Article Influence: 184.0] [Reference Citation Analysis]
21 Delanghe S, Biesen WV, Velde NVD, Eloot S, Pletinck A, Schepers E, Glorieux G, Delanghe JR, Speeckaert MM. Binding of bromocresol green and bromocresol purple to albumin in hemodialysis patients. Clinical Chemistry and Laboratory Medicine (CCLM) 2018;56:436-40. [DOI: 10.1515/cclm-2017-0444] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
22 Chen L, Chen DQ, Liu JR, Zhang J, Vaziri ND, Zhuang S, Chen H, Feng YL, Guo Y, Zhao YY. Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis. Exp Mol Med 2019;51:1-18. [PMID: 30918245 DOI: 10.1038/s12276-019-0234-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 13.0] [Reference Citation Analysis]
23 Lei J, Xie Y, Sheng J, Song J. Intestinal microbiota dysbiosis in acute kidney injury: novel insights into mechanisms and promising therapeutic strategies. Ren Fail 2022;44:571-80. [PMID: 35350960 DOI: 10.1080/0886022X.2022.2056054] [Reference Citation Analysis]
24 Schlender J, Behrens F, McParland V, Müller D, Wilck N, Bartolomaeus H, Holle J. Bacterial metabolites and cardiovascular risk in children with chronic kidney disease. Mol Cell Pediatr 2021;8:17. [PMID: 34677718 DOI: 10.1186/s40348-021-00126-8] [Reference Citation Analysis]
25 Wernimont SM, Radosevich J, Jackson MI, Ephraim E, Badri DV, MacLeay JM, Jewell DE, Suchodolski JS. The Effects of Nutrition on the Gastrointestinal Microbiome of Cats and Dogs: Impact on Health and Disease. Front Microbiol 2020;11:1266. [PMID: 32670224 DOI: 10.3389/fmicb.2020.01266] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
26 Hu X, Ouyang S, Xie Y, Gong Z, Du J. Characterizing the gut microbiota in patients with chronic kidney disease. Postgrad Med 2020;132:495-505. [PMID: 32241215 DOI: 10.1080/00325481.2020.1744335] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
27 Ahlawat S, Asha, Sharma KK. Gut-organ axis: a microbial outreach and networking. Lett Appl Microbiol 2021;72:636-68. [PMID: 32472555 DOI: 10.1111/lam.13333] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
28 Mahmoodpoor F, Rahbar Saadat Y, Barzegari A, Ardalan M, Zununi Vahed S. The impact of gut microbiota on kidney function and pathogenesis. Biomedicine & Pharmacotherapy 2017;93:412-9. [DOI: 10.1016/j.biopha.2017.06.066] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 11.8] [Reference Citation Analysis]
29 Margiotta E, Caldiroli L, Callegari ML, Miragoli F, Zanoni F, Armelloni S, Rizzo V, Messa P, Vettoretti S. Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress. Toxins (Basel) 2021;13:472. [PMID: 34357944 DOI: 10.3390/toxins13070472] [Reference Citation Analysis]
30 Velasquez MT, Centron P, Barrows I, Dwivedi R, Raj DS. Gut Microbiota and Cardiovascular Uremic Toxicities. Toxins (Basel) 2018;10:E287. [PMID: 29997362 DOI: 10.3390/toxins10070287] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
31 Snelson M, Kellow NJ, Coughlan MT. Modulation of the Gut Microbiota by Resistant Starch as a Treatment of Chronic Kidney Diseases: Evidence of Efficacy and Mechanistic Insights. Adv Nutr 2019;10:303-20. [PMID: 30668615 DOI: 10.1093/advances/nmy068] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]
32 Zeleznik OA, Balasubramanian R, Zhao Y, Frueh L, Jeanfavre S, Avila-Pacheco J, Clish CB, Tworoger SS, Eliassen AH. Circulating amino acids and amino acid-related metabolites and risk of breast cancer among predominantly premenopausal women. NPJ Breast Cancer 2021;7:54. [PMID: 34006878 DOI: 10.1038/s41523-021-00262-4] [Reference Citation Analysis]
33 Wu IW, Lin CY, Chang LC, Lee CC, Chiu CY, Hsu HJ, Sun CY, Chen YC, Kuo YL, Yang CW, Gao SS, Hsieh WP, Chung WH, Lai HC, Su SC. Gut Microbiota as Diagnostic Tools for Mirroring Disease Progression and Circulating Nephrotoxin Levels in Chronic Kidney Disease: Discovery and Validation Study. Int J Biol Sci 2020;16:420-34. [PMID: 32015679 DOI: 10.7150/ijbs.37421] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
34 El Amouri A, Snauwaert E, Foulon A, Vande Moortel C, Van Dyck M, Van Hoeck K, Godefroid N, Glorieux G, Van Biesen W, Vande Walle J, Raes A, Eloot S. Dietary fibre intake is low in paediatric chronic kidney disease patients but its impact on levels of gut-derived uraemic toxins remains uncertain. Pediatr Nephrol 2021;36:1589-95. [PMID: 33387017 DOI: 10.1007/s00467-020-04840-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Ren Z, Fan Y, Li A, Shen Q, Wu J, Ren L, Lu H, Ding S, Ren H, Liu C, Liu W, Gao D, Wu Z, Guo S, Wu G, Liu Z, Yu Z, Li L. Alterations of the Human Gut Microbiome in Chronic Kidney Disease. Adv Sci (Weinh) 2020;7:2001936. [PMID: 33101877 DOI: 10.1002/advs.202001936] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
36 Guirong YE, Minjie Z, Lixin YU, Junsheng YE, Lin Y, Lisha S. [Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects]. Nan Fang Yi Ke Da Xue Xue Bao 2018;38:1401-8. [PMID: 30613005 DOI: 10.12122/j.issn.1673-4254.2018.12.01] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
37 Chung S, Barnes JL, Astroth KS. Gastrointestinal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review. Adv Nutr 2019;10:888-901. [PMID: 31165878 DOI: 10.1093/advances/nmz028] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
38 Ahonen L, Jäntti S, Suvitaival T, Theilade S, Risz C, Kostiainen R, Rossing P, Orešič M, Hyötyläinen T. Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients. Metabolites 2019;9:E184. [PMID: 31540069 DOI: 10.3390/metabo9090184] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
39 Gryp T, Huys GRB, Joossens M, Van Biesen W, Glorieux G, Vaneechoutte M. Isolation and Quantification of Uremic Toxin Precursor-Generating Gut Bacteria in Chronic Kidney Disease Patients. Int J Mol Sci 2020;21:E1986. [PMID: 32183306 DOI: 10.3390/ijms21061986] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 8.5] [Reference Citation Analysis]
40 Panickar KS, Jewell DE. The Benefit of Anti-Inflammatory and Renal-Protective Dietary Ingredients on the Biological Processes of Aging in the Kidney. Biology (Basel) 2018;7:E45. [PMID: 30274250 DOI: 10.3390/biology7040045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
41 Sabatino A, Regolisti G, Cosola C, Gesualdo L, Fiaccadori E. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease. Curr Diab Rep 2017;17. [DOI: 10.1007/s11892-017-0841-z] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 13.0] [Reference Citation Analysis]
42 Simões-silva L, Araujo R, Pestana M, Soares-silva I, Sampaio-maia B. The microbiome in chronic kidney disease patients undergoing hemodialysis and peritoneal dialysis. Pharmacological Research 2018;130:143-51. [DOI: 10.1016/j.phrs.2018.02.011] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
43 Jackson MA, Bell JT, Spector TD, Steves CJ. A heritability-based comparison of methods used to cluster 16S rRNA gene sequences into operational taxonomic units. PeerJ 2016;4:e2341. [PMID: 27635321 DOI: 10.7717/peerj.2341] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
44 Pongking T, Haonon O, Dangtakot R, Onsurathum S, Jusakul A, Intuyod K, Sangka A, Anutrakulchai S, Cha'on U, Pinlaor S, Pinlaor P. A combination of monosodium glutamate and high-fat and high-fructose diets increases the risk of kidney injury, gut dysbiosis and host-microbial co-metabolism. PLoS One 2020;15:e0231237. [PMID: 32267892 DOI: 10.1371/journal.pone.0231237] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
45 Yang H, Feng P, Xu Y, Hou Y, Ojo O, Wang X. The Role of Dietary Fiber Supplementation in Regulating Uremic Toxins in Patients With Chronic Kidney Disease: A Meta-Analysis of Randomized Controlled Trials. Journal of Renal Nutrition 2021;31:438-47. [DOI: 10.1053/j.jrn.2020.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
46 Ji L, Chen S, Gu G, Zhou J, Wang W, Ren J, Wu J, Yang D, Zheng Y. Exploration of Crucial Mediators for Carotid Atherosclerosis Pathogenesis Through Integration of Microbiome, Metabolome, and Transcriptome. Front Physiol 2021;12:645212. [PMID: 34108883 DOI: 10.3389/fphys.2021.645212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
47 Sato N, Kakuta M, Hasegawa T, Yamaguchi R, Uchino E, Murashita K, Nakaji S, Imoto S, Yanagita M, Okuno Y. Metagenomic profiling of gut microbiome in early chronic kidney disease. Nephrol Dial Transplant 2021;36:1675-84. [PMID: 32869063 DOI: 10.1093/ndt/gfaa122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
48 Lehto M, Groop PH. The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders. Front Endocrinol (Lausanne) 2018;9:553. [PMID: 30283404 DOI: 10.3389/fendo.2018.00553] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
49 Xiao J, Song J, Sa Y, Yuan L, Guo J, Sun Z. The Mechanisms of Improving IVF Outcomes of Liu-Wei-Di-Huang Pill Acting on DOR Patients. Evid Based Complement Alternat Med 2020;2020:5183017. [PMID: 33178317 DOI: 10.1155/2020/5183017] [Reference Citation Analysis]
50 Nemet I, Saha PP, Gupta N, Zhu W, Romano KA, Skye SM, Cajka T, Mohan ML, Li L, Wu Y, Funabashi M, Ramer-Tait AE, Naga Prasad SV, Fiehn O, Rey FE, Tang WHW, Fischbach MA, DiDonato JA, Hazen SL. A Cardiovascular Disease-Linked Gut Microbial Metabolite Acts via Adrenergic Receptors. Cell 2020;180:862-877.e22. [PMID: 32142679 DOI: 10.1016/j.cell.2020.02.016] [Cited by in Crossref: 83] [Cited by in F6Publishing: 83] [Article Influence: 41.5] [Reference Citation Analysis]
51 Viana SD, Nunes S, Reis F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis. Ageing Res Rev. 2020;62:101123. [PMID: 32683039 DOI: 10.1016/j.arr.2020.101123] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 18.5] [Reference Citation Analysis]
52 Huang W, Zhou L, Guo H, Xu Y, Xu Y. The role of short-chain fatty acids in kidney injury induced by gut-derived inflammatory response. Metabolism 2017;68:20-30. [DOI: 10.1016/j.metabol.2016.11.006] [Cited by in Crossref: 34] [Cited by in F6Publishing: 39] [Article Influence: 6.8] [Reference Citation Analysis]
53 Lustgarten MS. The Kidney-Gut-Muscle Axis in End-Stage Renal Disease is Similarly Represented in Older Adults. Nutrients 2019;12:E106. [PMID: 31905970 DOI: 10.3390/nu12010106] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Freed TA, Coresh J, Inker LA, Toal DR, Perichon R, Chen J, Goodman KD, Zhang Q, Conner JK, Hauser DM, Vroom KET, Oyaski ML, Wulff JE, Eiríksdóttir G, Gudnason V, Torres VE, Ford LA, Levey AS. Validation of a Metabolite Panel for a More Accurate Estimation of Glomerular Filtration Rate Using Quantitative LC-MS/MS. Clin Chem 2019;65:406-18. [PMID: 30647123 DOI: 10.1373/clinchem.2018.288092] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
55 Pallister T, Jackson MA, Martin TC, Zierer J, Jennings A, Mohney RP, MacGregor A, Steves CJ, Cassidy A, Spector TD, Menni C. Hippurate as a metabolomic marker of gut microbiome diversity: Modulation by diet and relationship to metabolic syndrome. Sci Rep 2017;7:13670. [PMID: 29057986 DOI: 10.1038/s41598-017-13722-4] [Cited by in Crossref: 90] [Cited by in F6Publishing: 84] [Article Influence: 18.0] [Reference Citation Analysis]
56 de Abreu ICME, de Albuquerque RCMF, Brandão ABP, Barssotti L, de Souza LB, Ferreira FG, de Oliveira LCG, Yokota R, Sparvoli LG, da Silva Dias D, Salgado MAC, Taddei C, De Angelis K, Casarini DE, Cunha TS. Saccharomyces boulardii exerts renoprotection by modulating oxidative stress, renin angiotensin system and uropathogenic microbiota in a murine model of diabetes. Life Sci 2022;:120616. [PMID: 35533758 DOI: 10.1016/j.lfs.2022.120616] [Reference Citation Analysis]
57 Pang X, Jia Z, Lu J, Zhang S, Zhang C, Zhang M, Lv J. A new method for quantitative detection of Lactobacillus casei based on casx gene and its application. BMC Biotechnol 2019;19:87. [PMID: 31823776 DOI: 10.1186/s12896-019-0587-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Maturana JL, Cárdenas JP. Insights on the Evolutionary Genomics of the Blautia Genus: Potential New Species and Genetic Content Among Lineages. Front Microbiol 2021;12:660920. [PMID: 33981291 DOI: 10.3389/fmicb.2021.660920] [Reference Citation Analysis]
59 Sierra A, Otero S, Rodríguez E, Faura A, Vera M, Riera M, Palau V, Durán X, Costa-garrido A, Sans L, Márquez E, Poposki V, Franch-nadal J, Mundet X, Oliveras A, Crespo M, Pascual J, Barrios C. The GenoDiabMar Registry: A Collaborative Research Platform of Type 2 Diabetes Patients. JCM 2022;11:1431. [DOI: 10.3390/jcm11051431] [Reference Citation Analysis]
60 Fernandes R, Viana SD, Nunes S, Reis F. Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1876-1897. [PMID: 30287404 DOI: 10.1016/j.bbadis.2018.09.032] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
61 Roager HM, Hansen LBS, Bahl MI, Frandsen HL, Carvalho V, Gøbel RJ, Dalgaard MD, Plichta DR, Sparholt MH, Vestergaard H, Hansen T, Sicheritz-pontén T, Nielsen HB, Pedersen O, Lauritzen L, Kristensen M, Gupta R, Licht TR. Colonic transit time is related to bacterial metabolism and mucosal turnover in the gut. Nat Microbiol 2016;1. [DOI: 10.1038/nmicrobiol.2016.93] [Cited by in Crossref: 159] [Cited by in F6Publishing: 149] [Article Influence: 26.5] [Reference Citation Analysis]
62 Gooding J, Cao L, Whitaker C, Mwiza JM, Fernander M, Ahmed F, Acuff Z, McRitchie S, Sumner S, Ongeri EM. Meprin β metalloproteases associated with differential metabolite profiles in the plasma and urine of mice with type 1 diabetes and diabetic nephropathy. BMC Nephrol 2019;20:141. [PMID: 31023251 DOI: 10.1186/s12882-019-1313-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
63 Lee YJ, Li KY, Wang PJ, Huang HW, Chen MJ. Alleviating chronic kidney disease progression through modulating the critical genus of gut microbiota in a cisplatin-induced Lanyu pig model. J Food Drug Anal 2020;28:103-14. [PMID: 31883598 DOI: 10.1016/j.jfda.2019.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
64 Ephraim E, Jewell DE. Effect of Nutrition on Age-Related Metabolic Markers and the Gut Microbiota in Cats. Microorganisms 2021;9:2430. [PMID: 34946032 DOI: 10.3390/microorganisms9122430] [Reference Citation Analysis]
65 Huang CF, Chen A, Lin SY, Cheng ML, Shiao MS, Mao TY. A metabolomics approach to investigate the proceedings of mitochondrial dysfunction in rats from prediabetes to diabetes. Saudi J Biol Sci 2021;28:4762-9. [PMID: 34354464 DOI: 10.1016/j.sjbs.2021.04.091] [Reference Citation Analysis]
66 Ray N, Jeong H, Kwon D, Kim J, Moon Y. Antibiotic Exposure Aggravates Bacteroides-Linked Uremic Toxicity in the Gut-Kidney Axis. Front Immunol 2022;13:737536. [DOI: 10.3389/fimmu.2022.737536] [Reference Citation Analysis]
67 Huang H, Li K, Lee Y, Chen M. Preventive Effects of Lactobacillus Mixture against Chronic Kidney Disease Progression through Enhancement of Beneficial Bacteria and Downregulation of Gut-Derived Uremic Toxins. J Agric Food Chem 2021;69:7353-66. [PMID: 34170659 DOI: 10.1021/acs.jafc.1c01547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 Stanford J, Charlton K, Stefoska-Needham A, Ibrahim R, Lambert K. The gut microbiota profile of adults with kidney disease and kidney stones: a systematic review of the literature. BMC Nephrol 2020;21:215. [PMID: 32503496 DOI: 10.1186/s12882-020-01805-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
69 Vacca M, Celano G, Calabrese FM, Portincasa P, Gobbetti M, De Angelis M. The Controversial Role of Human Gut Lachnospiraceae. Microorganisms 2020;8:E573. [PMID: 32326636 DOI: 10.3390/microorganisms8040573] [Cited by in Crossref: 104] [Cited by in F6Publishing: 108] [Article Influence: 52.0] [Reference Citation Analysis]
70 Di Iorio BR, Rocchetti MT, De Angelis M, Cosola C, Marzocco S, Di Micco L, di Bari I, Accetturo M, Vacca M, Gobbetti M, Di Iorio M, Bellasi A, Gesualdo L. Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study). J Clin Med 2019;8:E1424. [PMID: 31510015 DOI: 10.3390/jcm8091424] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 11.3] [Reference Citation Analysis]
71 Gupta N, Buffa JA, Roberts AB, Sangwan N, Skye SM, Li L, Ho KJ, Varga J, DiDonato JA, Tang WHW, Hazen SL. Targeted Inhibition of Gut Microbial Trimethylamine N-Oxide Production Reduces Renal Tubulointerstitial Fibrosis and Functional Impairment in a Murine Model of Chronic Kidney Disease. Arterioscler Thromb Vasc Biol 2020;40:1239-55. [PMID: 32212854 DOI: 10.1161/ATVBAHA.120.314139] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 14.0] [Reference Citation Analysis]
72 Porcu E, Gilardi F, Darrous L, Yengo L, Bararpour N, Gasser M, Marques-Vidal P, Froguel P, Waeber G, Thomas A, Kutalik Z. Triangulating evidence from longitudinal and Mendelian randomization studies of metabolomic biomarkers for type 2 diabetes. Sci Rep 2021;11:6197. [PMID: 33737653 DOI: 10.1038/s41598-021-85684-7] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
73 Ottosson F, Brunkwall L, Smith E, Orho-Melander M, Nilsson PM, Fernandez C, Melander O. The gut microbiota-related metabolite phenylacetylglutamine associates with increased risk of incident coronary artery disease. J Hypertens 2020;38:2427-34. [PMID: 32665522 DOI: 10.1097/HJH.0000000000002569] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
74 Amaretti A, Gozzoli C, Simone M, Raimondi S, Righini L, Pérez-Brocal V, García-López R, Moya A, Rossi M. Profiling of Protein Degraders in Cultures of Human Gut Microbiota. Front Microbiol 2019;10:2614. [PMID: 31803157 DOI: 10.3389/fmicb.2019.02614] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
75 Winther SA, Henriksen P, Vogt JK, Hansen TH, Ahonen L, Suvitaival T, Hein Zobel E, Frimodt-Møller M, Hansen TW, Hansen T, Parving HH, Legido-Quigley C, Rossing P, Pedersen O. Gut microbiota profile and selected plasma metabolites in type 1 diabetes without and with stratification by albuminuria. Diabetologia 2020;63:2713-24. [PMID: 32886190 DOI: 10.1007/s00125-020-05260-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]